ReviewRadiologic clinics of North America2017
Imaging and Screening of Kidney Cancer.
Review in Radiologic clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.World journal of urology · 2023Pooled it
- CT radiomics for differentiating oncocytoma from renal cell carcinomas: Systematic review and meta-analysis.Clinical imaging · 2023Pooled it
- Available active surveillance follow-up protocols for small renal mass: a systematic review.World journal of urology · 2021Pooled it
- Clinicohistopathological characteristics of renal cell carcinoma in Jordan.Future science OA · 2026Article
- MRI annotation using an inversion-based preprocessing for CT model adaptation.European radiology experimental · 2025Article
- Computed Tomography-Based Radiomics Diagnostic Model for Fat-Poor Small Renal Tumor Subtypes.Diagnostics (Basel, Switzerland) · 2025Article
- Prediction of Distant Metastasis of Renal Cell Carcinoma Based on Interpretable Machine Learning: A Multicenter Retrospective Study.Journal of multidisciplinary healthcare · 2025Article
- Aggressiveness classification of clear cell renal cell carcinoma using registration-independent radiology-pathology correlation learning.Medical physics · 2025Article
- Detection and Validation of Organic Metabolites in Urine for Clear Cell Renal Cell Carcinoma Diagnosis.Metabolites · 2024Article
- Patient-specific, deliverable, and self-expandable surgical guide development and evaluation using 4D printing for laparoscopic partial nephrectomy.Scientific reports · 2024Article
- Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender-specific two-sample Mendelian randomization study.Cancer medicine · 2023Article
- Simultaneous surgery of an inflammatory abdominal aortic aneurysm and renal cell carcinoma: A case report.International journal of surgery case reports · 2023Article
- Complications after Nephron-sparing Interventions for Renal Tumors: Imaging Findings and Management.Radiographics : a review publication of the Radiological Society of North America, Inc · 2023Article
- Underlying mechanisms of change in cancer prevalence in older U.S. adults: contributions of incidence, survival, and ascertainment at early stages.Cancer causes & control : CCC · 2022Article
- Molecular signature of renal cell carcinoma by means of a multiplatform metabolomics analysis.Biochemistry and biophysics reports · 2022Article
- Evaluation of Renal Function after Partial Nephrectomy and Detection of Clinically Significant Acute Kidney Injury.Medicina (Kaunas, Lithuania) · 2022Observational
- Machine Learning-Enabled Renal Cell Carcinoma Status Prediction Using Multiplatform Urine-Based Metabolomics.Journal of proteome research · 2021Article
- Deep learning for end-to-end kidney cancer diagnosis on multi-phase abdominal computed tomography.NPJ precision oncology · 2021Article
- Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer.OncoTargets and therapy · 2021Review
- Imaging for Metastatic Renal Cell Carcinoma.The Urologic clinics of North America · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Renal cell carcinoma (RCC) exhibits a diverse and heterogeneous disease spectrum, but insight into its molecular biology has provided an improved understanding of potential risk factors, oncologic behavior, and imaging features. Computed tomography (CT) and MR imaging may allow the identification and preoperative subtyping of RCC and assessment of a response to various therapies. Active surveillance is a viable management option in some patients and has provided further insight into the natural history of RCC, including the favorable prognosis of cystic neoplasms. This article reviews CT and MR imaging in RCC and the role of screening in selected high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.